MYD88 and esophageal cancer: With regard to esophageal cancer cells, it has been shown that activation of TLR4 stimulates cell proliferation through the TLR4-MyD88-TRAF6-NF-κB signaling pathway, and the inhibition of NF-κB leads to the inhibition of proliferation [61].